Pfizer Sues Rival in Va. Court Over Generic Viagra

March 31, 2010

Pfizer Inc. has filed a lawsuit against a rival drug maker that plans to introduce a generic version of Viagra.

Pfizer alleges in its lawsuit in U.S. District Court in Norfolk that Teva Pharmaceuticals plans to roll out its version of sildenafil citrate in 2012, which Pfizer says would violate one of its patents.

If Teva succeeds, it would cut into Pfizer's sales of its erectile-dysfunction drug, worth more than $1 billion annually.

New York-based Pfizer has asked the court to bar Teva from making or distributing a generic version of Viagra before 2019. Teva is based in Israel.

Teva spokeswoman Denise Bradley declined to comment on the lawsuit. A Pfizer spokesman didn't comment Tuesday.

The comments sections of are designed for thoughtful, intelligent conversation and debate. We want to hear from our viewers, but we ask that you follow our rules for commenting. E-mail is required to comment on a story, but it will not be displayed with your comment. For complete rules, CLICK HERE. The Newsplex reserves the right to not post or to remove any comment.
powered by Disqus
The Charlottesville Newsplex 999 2nd Street S.E. Charlottesville, VA 22902 434.242.1919 – Main 434.220.7522 - Newsroom
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 89597422 -